The effects of high dose methotrexate in patients with neoplastic diseases: A prospective study

Iranian Red Crescent Medical Journal

Volumn 10, Issue 2, 2008, Pages 75-78

  Mashhadi, Mohammed Ali ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepathotoxicity; Methotrexate; Side effects

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM; CHROMIUM; FOLINIC ACID; GRANISETRON; METHOTREXATE; METOCLOPRAMIDE; POTASSIUM; SODIUM; URIC ACID;

ABDOMINAL PAIN; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLERGIC REACTION; ALOPECIA; ARTICLE; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CHORIOCARCINOMA; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DIZZINESS; DRUG ERUPTION; DRUG MEGADOSE; DRUG SAFETY; ELECTROCARDIOGRAM; ELECTROLYTE DISTURBANCE; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HOSPITAL ADMISSION; HUMAN; KIDNEY FUNCTION; LABORATORY TEST; LIVER FUNCTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEOPLASM; NEPHROTOXICITY; ONCOLOGY WARD; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; STOMATITIS; UREA NITROGEN BLOOD LEVEL;

EID: 69749109649     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Allergra CJ, Grem JL. Antimetabolites. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practices of Oncology, 5th edition. Philadelphia: Lippincott-Raven 1997; 432-465.
2. Wolfe F, Cathey MA. The effect of age on methotrexate efficacy and toxicity. J Rheumatol 1991;18:973-7.
3. McKendry RJ, Dale P. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J Rheumatol 1993;20:1850-6.
4. Bologna C, Viu P, Picot MC, Jorgensen C, Sany J. Long-term follow-up of 453 rheumatoid arthritis patients treated with methotrexate: an open retrospective, observational study. Br J Rheumatol 1997; 36:535-40.
5. Kremer JM, Lee RG, Tolman KG. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. Arthritis Rheum 1989;32:121-7.
6. Suzuki Y, Uehara R, Tajima C, Noguchi A, Ide M, Ichikawa Y, Mizushima Y. Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate. Risk factors and response to folic acid. Scand J Rheumatol 1999; 28(5):273-81.
7. van Ede AE, Laan RF, Rood MJ, Huizinga TW, van de Laar MA, van Denderen CJ, Westgeest TA, Romme TC, de Rooij DJ, Jacobs MJ, de Boo TM, van der Wilt GJ, Severens JL, Hartman M, Krabbe PF, Dijkmans BA, Breedveld FC, van de Putte LB. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2002; 46(5):1413-4.
8. Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL, Alarcón GS. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 1990;33(1):9-18.
9. Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY, Koopman WJ, Krumdieck CL, Alarcón GS. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind placebo-controlled trial. Ann Intern Med 1994;121:833-41.
10. McEvoy G (ed). Methotrexate. In: American Hospital Formulary Service 2000. Bethesda: American Society of Health System Pharmacists 2000;1011-1019.
11. Glass J, Gruber ML, Cher L, Hochberg FH. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994;81(2):188-95.
12. Batchelor T, Carson K, O'Neill A, Grossman SA, Alavi J, New P, Hochberg F, Priet R. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clini Oncol 2003;21:1044-1049.
13. Guha-Thakurta N, Damek D, Pollack C, Hochberg FH. Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients. J Neurooncol 1999;43(3):259-68.
14. Jahnke K, Korfel A, Martus P, Weller M, Herrlinger U, Schmittel A, Fischer L, Thiel E. German Primary Central Nervous System Lymphoma Study Group (G-PCNSL-SG). High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma. Ann Oncol 2005; 16(3):445-9.